Article Details

Broad-based genomic screening benefits questioned for advanced NSCLC

Retrieved on: 2018-08-08 23:22:30

Tags for this article:

Click the tags to see associated articles and topics

Broad-based genomic screening benefits questioned for advanced NSCLC. View article details on hiswai:

Excerpt

<div>The team collated information from the <b>Flatiron Health</b> Database for 5688 patients with stage IIIB/IV, or recurrent or progressive early-stage NSCLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up